Arvinas Announces Upcoming Bavdegalutamide Poster Presentation at ESMO Congress 2023

BY admin admin

<p>NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it will present updated Phase 1/2 trial data for bavdegalutamide (ARV-110) at the 2023 European Society for Medical Oncology (ESMO) Annual Congress. Bavdegalutamide is an [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/arvinas-announces-upcoming-bavdegalutamide-poster-presentation-at-esmo-congress-2023/">Arvinas Announces Upcoming Bavdegalutamide Poster Presentation at ESMO Congress 2023</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Forex

Baker Hughes oil rigs 497 vs 495 last week

Oil rigs 497 vs 495 last weekGas rigs 115 vs 114 last weekTotal rigs 613 vs 610 last weekCrude oil is trading at $92.35, up $2.08 on the day.

Forex

China’s Stimulus Casts Doubts on Copper and Aussie Dollar Performance

<p>China’s stimulus measures fall short, hindering economic recovery and casting doubts on copper and the Australian dollar (AUD). The recent 10 basis points cut in benchmark lending rates

Forex

Weekly Market Wrap with Gary Thomson: UK100 DROPS 1.5%, USD RISES, OPEC’S FORECASTS, MICROSOFT SURPASSES APPLE

<img src="https://fxopen.com/blog/en/content/images/2024/01/Wrap-video–15-19-January_en.png" alt="Weekly Market Wrap with Gary Thomson: UK100 DROPS 1.5%, USD RISES, OPEC’S FORE

Copyright © 2024 | WordPress Theme: Xews Lite